Skip to content
etf.net

Launched · SEC filings

Invesco Nasdaq Biotechnology ETF

IBBQNasdaqInvescoA

$36.28−0.56 (−1.53%)

As of Nov 10, 2026, 11:15 AM ET

A77/ 100

Rank 2 of 17 in Biotech & Genomics

A77/100Rank 2 of 17inBiotech & Genomics
Intraday session: down, 22 prints from 36.85 to 36.28. Range 36.28 to 36.73. Use the arrow keys to read each point.36.4036.5036.6036.7010 AM12 PM2 PM4 PM
Expense ratio
0.19%
Fund size
$128M
1Y total return
+41.3%
Yield · Last 12 months
1.06%
Holdings
248
Avg volume · 30D
40.4K sh
52W range
low $26.57high $37.01
Launched
Filings
SEC EDGAR

The ETF.net IBBQ Grade

A

Score 77 out of 100

Category
Biotech & Genomics⁠
Rank
2 of 17
Six-pillar profile for IBBQ. Scores out of 100: Cost 100, Risk 75, Mission 84, Tradability 53, Holdings 55, Durability 42. Strongest: Cost (100). Weakest: Durability (42). Leans toward Cost.

Score 77 of 100 falls in the A band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    A100 out of 100
    Rank 1 of 17

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    A84 out of 100
    Rank 4 of 9

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    A75 out of 100
    Rank 1 of 17

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C53 out of 100
    Rank 7 of 17

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    B55 out of 100
    Rank 10 of 17

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C42 out of 100
    Rank 13 of 17

Our read on IBBQ

ETF.net Research

In short

AThe broad Nasdaq biotech benchmark, bought cheap. IBBQ tracks the whole listed biotech and pharma field, roughly 300 names, for 0.19% a year, well under half the typical fee in its category.

Stated mandate

The Fund tracks the Nasdaq Biotechnology Index and normally invests at least 90% of its assets in index constituents. The index covers Nasdaq-listed companies classified as biotechnology or pharmaceutical companies.

Why people hold it

  • At 0.19% a year, the lowest fee among its closest biotech rivals and less than half the category median.
  • Holds roughly 300 Nasdaq-listed biotech and pharma companies, so one failed trial or one blockbuster is a slice of the fund, not the whole story.invesco.com
  • Rules first: normally at least 90% of assets sit in Nasdaq Biotechnology Index constituents. No manager guessing which pipeline pays off.invesco.com
  • Stands in the top quartile of the biotech and genomics funds we grade, keeping company with far larger rivals like XBI and IBB.

Worth knowing

  • Thinly traded next to the category's giants, so bid-ask spreads can widen. Limit orders matter more here than in a heavily traded fund.
  • One sector, and a jumpy one: biotech and pharma prices move on trial data and regulatory decisions, a rougher ride than a broad-market fund.invesco.com
  • Launched in 2021, so a shorter live record and a smaller asset base than the category's long-standing funds.

IBBQ Performance

Launched Jun 11, 2021

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
IBBQ$14,134
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,339
Nov 7, 2025 to Nov 9, 2026. IBBQ $14,134. SPY $11,339. Use the arrow keys to read each point.$10,000$12,000$14,000Nov 2025May 2026Nov 2026

Nov 7, 2025 – Nov 9, 2026

Returns run to the Nov 9, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for IBBQ. Periods over one year show the average yearly return.
PeriodIBBQ
Year to date+30.9%
1 month+6.4%
3 months+10.0%
1 year+41.3%
3 yearsper year+27.1%
5 yearsper year+9.4%
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for IBBQ
YearReturn barIBBQ
2026 YTD+30.9%
2025+33.3%
2024−0.6%
2023+4.7%
2022−10.4%
2021−6.7%

Since listing, Jun 11, 2021

IBBQ in the news

IBBQ Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Nov 9, 2026.
1.06%Last 12 months
Payout per share
$0.39Last 12 months
Last payment
$0.23 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2021–2026

One bar per payment. 21 payments from 2021 to 2026 YTD. Sep 20, 2021 $0.04; Dec 20, 2021 $0.11; Mar 21, 2022 $0.04; Jun 21, 2022 $0.04; Sep 19, 2022 $0.04; Dec 19, 2022 $0.04; Mar 20, 2023 $0.04; Jun 20, 2023 $0.05; Sep 18, 2023 $0.04; Dec 18, 2023 $0.05; Mar 18, 2024 $0.04; Jun 24, 2024 $0.05; Sep 23, 2024 $0.09; Dec 23, 2024 $0.06; Mar 24, 2025 $0.04; Jun 23, 2025 $0.03; Sep 22, 2025 $0.10; Dec 22, 2025 $0.09; Mar 23, 2026 $0.04; Jun 22, 2026 $0.03; Sep 21, 2026 $0.23. Use the arrow keys to read each point.202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 21, 2026Sep 25, 2026$0.23
Jun 22, 2026Jun 26, 2026$0.03
Mar 23, 2026Mar 27, 2026$0.04
Dec 22, 2025Dec 26, 2025$0.09
Sep 22, 2025Sep 26, 2025$0.10
Jun 23, 2025Jun 27, 2025$0.03
Mar 24, 2025Mar 28, 2025$0.04
Dec 23, 2024Dec 27, 2024$0.06
Sep 23, 2024Sep 27, 2024$0.09
Jun 24, 2024Jun 28, 2024$0.05
Mar 18, 2024Mar 22, 2024$0.04
Dec 18, 2023Dec 22, 2023$0.05

See all 21 payments⁠

$10,000 in IBBQ 5 years ago paid $509 in dividends.⁠

IBBQ Risk

Risk pillarA75 out of 100Rank 1 of 17 in Biotech & Genomics
How much the fund’s monthly returns vary, scaled to a year.
16.8%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
1.22
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−31.1%
Trough Jun 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.63
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

IBBQ Cost

Cheapest in Biotech & Genomics

$3,952

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • IBBQ 0.19%

    $3,952

$10,000
30 years

Cost over time

  • IBBQ 0.19%
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$1K$2K$3K$4K051015202530IBBQ $3,952

Year by year

YearIBBQ
10$347
20$1,351
30$3,952

Other funds in Biotech & Genomics

See others